Treatment of Peyronie's Disease

 


Specific treatment for Peyronie's disease will be determined by your physician based on your:

  • Age, overall health, and medical history
  • Extent of the disease
  • Tolerance for specific medications, procedures, or therapies
  • Expectations for the course of the disease
  • Opinion or preference

In general, the goal of treatment is to keep the patient with Peyronie's disease sexually active. Providing education about the disease and its course is often included in the treatment plan. In some cases, treatment is not necessary, as Peyronie's disease often occurs in a mild form that heals without treatment in 6 to 15 months.

Treatment may include:

  • Prescribing or continuing palliative methods
  • Surgery
  • Vitamin E - small studies have reported improvements with oral vitamin E prescribed by a physician. However, larger controlled studies have not been completed to establish the effectiveness of this treatment
  • Injections of various chemical agents into plaque - have been used in a small number of patients, and for this reason, this intervention is considered unproven. Unwanted side effects may occur
  • Radiation Therapy - with this treatment approach, radiation is aimed at the plaque to reduce pain, but does not affect the plaque itself; unwanted side effects or worsening of the disease may occur.

 

Latest Peyronie's Disease News
Enzyme injections unlock bent fingers

September 3, 2009 — BOSTON (Reuters) - Injections of an enzyme that breaks up collagen can unlock permanently curled fingers for people with a common disabling condition known as Dupuytren's contracture, U.S. researchers said on Wednesday.

Verapamil can slow Peyronie's disease progression

July 26, 2007 — NEW YORK (Reuters Health) - Injections of verapamil directly into the penis in patients with Peyronie's disease resulted in a reduction in curvature of the penis in 18 percent of the patients and disease stabilization in 60 percent, according to the results of a new study.

Select news items provided by Reuters Health